|
RLAY Relay Therapeutics Inc 1812364 |
| Balance Sheet |
|
Current Assets
|
$658,462,000.00 |
|
Assets
|
$699,613,000.00 |
|
Current Liabilities
|
$29,751,000.00 |
|
Liabilities
|
$57,430,000.00 |
|
Equity
|
$642,183,000.00 |
|
Shares Out
|
189209453.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-51,112,000.00 |
|
Investing Cash Flow
|
$32,901,000.00 |
| Market Analysis |
Market Cap
|
$3,680,123,860.85 |
|
Price
|
$18.29 |
|
BVPS
|
3.39 |
|
PB
|
5.74 |
|
EPS
|
-0.41 |
|
PS
|
280.03 |
|
FCF
|
$-51,522,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:15 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.32 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
-0.41 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.43 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RLAY documents filed with the SEC.
RLAY Filings
Clear
